Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Regulatory News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.50
Bid: 48.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.083%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.50
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

3 May 2018 07:00

RNS Number : 9410M
Cambridge Cognition Holdings PLC
03 May 2018
 

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

 

Grant of Options

 

The digital neuroscience company Cambridge Cognition Holdings plc (AIM: COG, 'the Company'), which develops and markets software products to assess brain health, announces that on 2 May 2018, the Company granted options ("Options") over a total of 404,500 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") pursuant to the Company's EMI option scheme and the Company's unapproved option scheme.

Of these Options:

- 225,000 were granted to Persons Discharging Managerial Responsibilities ("PDMRs") on behalf of the Company; and

- 179,500 were granted to other employees of the Company.

The 225,000 Options granted to PDMRs together with 170,500 of the 179,500 Options granted to other employees are exercisable at a price of 1 pence per Ordinary Share from three years following the date of award until the tenth anniversary of the date of award, subject to satisfying the following performance criteria:

- 55% of the Options granted will vest if the average closing mid-market price of an Ordinary Share for the final 10 trading days of 2019 is greater than 170 pence per Ordinary Share. A pro rata sliding scale will apply if the average closing mid-market price of an Ordinary Share for the final 10 trading days of 2019 is between 130 pence and 170 pence per Ordinary Share; and

- 45% of the Options granted will vest if the Company reports a post-tax profit in the audited accounts in both of the two financial years ended 31 December 2018 and 31 December 2019. If this is achieved in only one of these years, then 10% of the Options will vest.

The remaining 9,000 Options are exercisable at a price of 1 pence per Ordinary Share from two years following the date of award until the tenth anniversary of the date of award. All of these Options are granted over shares already in issue and held by Cambridge Cognition Trustees Limited on behalf of the Employee Benefit Trust.

Following the grant of Options, the total number of Options outstanding over unissued Ordinary Shares is 2,198,106, representing approximately 10.62% of the Company's issued share capital.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Names

Steven Powell - Chief Executive Officer

Nicholas Walters - Chief Financial Officer

Jennifer Barnett - Chief Scientific Officer

Mark Miller-Holliday - Director of International Sales and Business Development

Ricky Dolphin - Technical & Operations Director

2.

Reason for the Notification

a)

Position/status

See 1(a) above for positions - all classified as PDMRs of the Company

b)

Initial notification/ Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cambridge Cognition Holdings Plc

b)

LEI

213800SZKDIN122EPA96

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

In each case, the grant of Options over Ordinary Shares on 2 May 2018

 

Identification code

GB00B8DV9647

b)

Nature of the transaction

Grant of Options over Ordinary Shares

 

c)

Price(s) and volume(s)

Price: n/a

Volumes:

Steven Powell - 100,000 Options

Nicholas Walters - 25,000 Options

Jennifer Barnett - 25,000 Options

Mark Miller-Holliday - 50,000 Options

Ricky Dolphin - 25,000 Options

d)

Aggregated information:

· Aggregated volume

· Price

n/a

e)

Date of the transaction

2 May 2018

f)

Place of the transaction

Outside a trading venue

 

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014

Enquiries

Cambridge Cognition Holdings PLC

Steven Powell, Chief Executive Officer

Nick Walters, Chief Financial Officer

Tel: 01223 810 700

 

finnCap Ltd (NOMAD and Joint Broker)

Tel: 020 7220 0500

Geoff Nash / Simon Hicks

(Corporate Finance)

Alice Lane

(Corporate Broking)

 

Dowgate Capital Stockbrokers Limited (Joint Broker)

David Poutney/ James Serjeant

Tel: 020 3903 7715

(Corporate Broking)

IFC Advisory Limited (Financial PR and IR)

Tel: 020 3934 6630

Graham Herring/ Miles Nolan/ Zach Cohen

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHELLFBVEFZBBK
Date   Source Headline
27th Feb 20184:25 pmRNSHolding(s) in Company
10th Jan 20187:00 amRNSTrading Update and Notice of Results
5th Dec 20178:55 amRNSHolding(s) in Company
28th Nov 20177:00 amRNSWearable technology demonstrates high compliance
2nd Nov 20177:00 amRNSGrant of Options
10th Oct 201711:00 amRNSHolding(s) in Company
10th Oct 201710:58 amRNSHolding(s) in Company
6th Oct 20177:00 amRNSIssue of Equity
21st Sep 20177:00 amRNSHalf-year Report
12th Sep 20177:00 amRNSAward of Funding
31st Aug 20177:00 amRNSNotice of Results
12th Jun 20179:56 amRNSHolding(s) in Company
8th Jun 20177:00 amRNSDirector/PDMR Shareholding
7th Jun 20177:00 amRNSSpeech recognition for clinical trials
25th May 20172:22 pmRNSResult of AGM & Board Change
24th May 20174:27 pmRNSHolding(s) in Company
22nd May 20177:00 amRNSIssue of Equity
11th May 20171:07 pmRNSHolding(s) in Company
10th May 20177:00 amRNSGrant of Options
2nd May 20177:00 amRNSPosting of Annual Report & Notice of AGM
30th Mar 20177:00 amRNSDirector/PDMR Shareholding
29th Mar 20177:00 amRNSAnnual Financial Report
16th Mar 20177:00 amRNSCANTAB used in EBBINGHAUS cognitive function trial
7th Mar 20177:00 amRNSLaunch of web-based testing for virtual research
24th Feb 20177:00 amRNSPartnership With Takeda For Wearables
23rd Feb 20177:00 amRNSNotice of Results
20th Feb 20177:00 amRNSAppointment of Joint Broker
25th Jan 20177:00 amRNSUS regulatory clearance for CANTAB Mobile
4th Nov 20167:00 amRNSGrant of Options
13th Oct 20167:00 amRNSContract
29th Sep 20167:00 amRNSContract Win
22nd Sep 20167:00 amRNSHalf Yearly Report
20th Sep 20167:00 amRNSContract signed
25th Aug 20167:00 amRNSNotice of Results
18th Aug 201610:27 amRNSHolding(s) in Company
16th Aug 20167:00 amRNSCognition Kit Feasibility Study
20th Jul 20167:00 amRNSContract Win
24th Jun 201612:33 pmRNSResult of AGM
22nd Jun 20167:00 amRNSDistribution Agreement with MANUS Neurodynamica
2nd Jun 20167:00 amRNSDistribution Agreement with AnthroTronix
25th May 20162:00 pmRNSNotice of AGM & Posting of Annual Report
6th May 20167:00 amRNSDirector Dealing
5th May 20167:00 amRNSCANTAB Mobile - submission for FDA clearance
3rd May 20163:06 pmRNSHolding(s) in Company
25th Apr 20162:00 pmRNSDirector Dealing
25th Apr 20167:01 amRNSPlacing to raise £1.25m
25th Apr 20167:00 amRNSFinal Results
11th Apr 20167:00 amRNSCANTAB Recruit release
4th Apr 20167:00 amRNSPresentation of Prototype Wearable
30th Mar 20164:06 pmRNSAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.